Thirdly, the community pharmacist leader wanted the drug regulator to clarify whether the restriction and labelling requirements are applicable to the FDC, paracetamol and chlorpheniramine maleate and ...

The Centre has formally restricted the manufacture and sale of fixed drug combinations (FDCs) of chlorpheniramine maleate and phenylephrine hydrochloride for use in children under four years of age.